載入...
Gut microbiome modulates efficacy of immune checkpoint inhibitors
Immune checkpoint inhibitors (ICIs) therapy is a novel strategy for cancer treatments in recent years. However, it was observed that most patients treated with ICIs could not get benefit from the therapy, which led to the limitation of clinical application. Motivated by potent and durable efficacy o...
Na minha lista:
| 發表在: | J Hematol Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5870075/ https://ncbi.nlm.nih.gov/pubmed/29580257 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-018-0592-6 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|